SCHEMBL3538657

SCHEMBL3538657

CC(C)(C1CC=CCC1)C1CCCCC1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3549870 0.89 ALDH1A1 (0.36) ALDH1A1ALOX15
SCHEMBL3552259 0.80
SCHEMBL9868537 0.78
SCHEMBL29024831 0.76 EPHX1 (0.33) ALDH1A1
SCHEMBL9016315 0.76 EPHX1 (0.33) ALDH1A1
SCHEMBL133604 0.76 EPHX1 (0.33) ALDH1A1
SCHEMBL455930 0.75 ALDH1A1 (0.36) ALDH1A1ALOX15
SCHEMBL3545061 0.75
Benzene SCHEMBL3916200 0.74 KEAP1 (0.34)
SCHEMBL19809440 0.74 EPHX1 (0.37) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101087772-B High-purity alicyclic diepoxy compound and preparation method thereof DAICEL CHEM 2012-05-09 CN disclosed
CN-1934098-B High-purity alicyclic epoxy compound, process for producing the same, curable epoxy resin composition, cured article thereof, and use DAICEL CHEM 2012-04-25 CN disclosed
US-7732627-B2 High-purity cycloaliphatic diepoxy compound and preparation process thereof DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-08 US disclosed
US-20080045729-A1 High-Purity Cycloaliphatic Diepoxy Compound and Preparation Process Thereof DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2008-02-21 US disclosed
EP-1834949-A1 HIGH-PURITY ALICYCLIC DIEPOXY COMPOUND AND PROCESS FOR PRODUCING THE SAME Daicel Chemical Industries, Ltd. (JP) 2007-09-19 EP disclosed
US-20070179256-A1 High-purity alicyclic epoxy compound, process for production of the same, curable epoxy resin composition, cured product thereof, and application thereof DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2007-08-02 US disclosed
CN-1934098-A High-purity alicyclic epoxy compound, process for producing the same, curable epoxy resin composition, cured article thereof, and use DAICEL CHEM (JP) 2007-03-21 CN disclosed
EP-1726588-A1 HIGH-PURITY ALICYCLIC EPOXY COMPOUND, PROCESS FOR PRODUCING THE SAME, CURABLE EPOXY RESIN COMPOSITION, CURED ARTICLE THEREOF, AND USE Daicel Chemical Industries, Ltd. (JP) 2006-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045729-A1 High-Purity Cycloaliphatic Diepoxy Compound and Preparation Process Thereof DUOX2, SQLE, HPD ALDH1A1 3377/4885ALOX15 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.